137 related articles for article (PubMed ID: 22245963)
1. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
Erichsen R; Robertson D; Farkas DK; Pedersen L; Pohl H; Baron JA; Sørensen HT
Clin Gastroenterol Hepatol; 2012 May; 10(5):475-80.e1. PubMed ID: 22245963
[TBL] [Abstract][Full Text] [Related]
2. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
3. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study.
Ronkainen J; Talley NJ; Storskrubb T; Johansson SE; Lind T; Vieth M; Agréus L; Aro P
Am J Gastroenterol; 2011 Nov; 106(11):1946-52. PubMed ID: 21946284
[TBL] [Abstract][Full Text] [Related]
4. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
5. Cancer after repair of esophageal atresia: population-based long-term follow-up.
Sistonen SJ; Koivusalo A; Lindahl H; Pukkala E; Rintala RJ; Pakarinen MP
J Pediatr Surg; 2008 Apr; 43(4):602-5. PubMed ID: 18405703
[TBL] [Abstract][Full Text] [Related]
6. Long-term complications to reflux disease in community practice. A 17-year cohort study of 4706 patients.
Hvid-Jensen F; Pedersen L; Munk EM; Drewes AM; Funch-Jensen P
Scand J Gastroenterol; 2011 Oct; 46(10):1179-86. PubMed ID: 21793632
[TBL] [Abstract][Full Text] [Related]
7. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
8. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux and cancer.
Turcotte S; Duranceau A
Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
[TBL] [Abstract][Full Text] [Related]
11. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Lagergren J; Mattsson F; Nyrén O
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):45-51. PubMed ID: 23920035
[TBL] [Abstract][Full Text] [Related]
13. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus.
Schouten LJ; Steevens J; Huysentruyt CJ; Coffeng CE; Keulemans YC; van Leeuwen FE; Driessen AL; van den Brandt PA
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):754-61. PubMed ID: 21570484
[TBL] [Abstract][Full Text] [Related]
14. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis.
Wang PC; Hsu CS; Tseng TC; Hsieh TC; Chen CH; Su WC; Lin HH; Wang CC
J Gastroenterol Hepatol; 2012 Mar; 27(3):586-91. PubMed ID: 21871022
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
[TBL] [Abstract][Full Text] [Related]
16. No association between gastroesophageal reflux and cancers of the larynx and pharynx.
Nilsson M; Chow WH; Lindblad M; Ye W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1194-7. PubMed ID: 15894671
[TBL] [Abstract][Full Text] [Related]
17. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
18. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
19. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
Lagergren J
Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
[TBL] [Abstract][Full Text] [Related]
20. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.
Tran T; Spechler SJ; Richardson P; El-Serag HB
Am J Gastroenterol; 2005 May; 100(5):1002-8. PubMed ID: 15842570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
